We have installed ReadSpeaker’s webReader, which allows visitors to instantly convert online content to audio on our website.
Click on the icon above to try this out, and take advantage of the full range of useful webReader features by clicking the link below.
Readspeaker website
This accessibility statement applies to www.audit.wales. This website is run by Audit Wales. We want as many people as possible to be able to use this website.
View accessibility statement
We’re always looking to improve the accessibility of this website. If you find any problems not listed on this page or think we’re not meeting accessibility requirements, contact:
info@audit.wales
After a period of significant disruption during 2023, the board is in a more stable position and working relationships amongst senior leaders are more positive overall.
However, there are still fundamental challenges to address, including building a high performing executive team, recruiting substantively to remaining posts on the board, and ensuring the new board demonstrates the unified and effective leadership that is needed to tackle the challenges the organisation faces.
In February 2023, the Auditor General published a report in the public interest that described a worrying level of dysfunctionality within the board at Betsi Cadwaladr University Health Board. The report highlighted a need for immediate action to address fractured working relationships between the health board’s senior leaders that were fundamentally compromising the board’s ability to tackle the substantial challenges the organisation faces.
Following significant changes to the board membership over the last 12 months, and a period of upheaval and churn, the follow-up report that we’re publishing today describes a board that is now more stable.
The dysfunctionality that we described in our previous report is no longer present, and a new substantive Chair and Chief Executive are providing refreshed and focused leadership to tackle the organisation’s challenges. Reliance on interim appointments to senior roles is reducing and action is being taken to strengthen corporate governance leadership arrangements.
However, further action in a number of areas is still needed. Work must continue to build a cohesive and high performing executive team and to move as quickly as possible to a position where the board has a full complement of substantive executive directors and independent members.
Governance structures that were stood down in 2023 following the resignation of the previous independent members need to be built back up and the issues that led to the suspension of staff in the finance team need to be resolved.
Crucially, our report highlights the need for the organisation to develop its internal capacity and resilience to sustain improvement without requiring continual external support.
It’s assuring to see that the dysfunction within the health board’s senior leadership that we described last year is no longer present. There is now a need for the board to build upon this progress and provide the unified organisational leadership that is needed to address the significant and on-going challenges facing the health board.